198 related articles for article (PubMed ID: 2465574)
61. Targeted therapy in metastatic renal cell carcinoma.
De Mulder PH
Ann Oncol; 2007 Jul; 18 Suppl 9():ix98-102. PubMed ID: 17631605
[No Abstract] [Full Text] [Related]
62. The role of biological response modifiers in metastatic renal cell carcinoma.
Muss HB
Semin Oncol; 1988 Oct; 15(5 Suppl 5):30-4. PubMed ID: 2461595
[No Abstract] [Full Text] [Related]
63. Biologic response modifiers in the therapy of metastatic renal cell carcinoma.
Quesada JR
Semin Oncol; 1988 Aug; 15(4):396-407. PubMed ID: 2457256
[No Abstract] [Full Text] [Related]
64. Biological therapy for metastatic renal cell cancer.
Lancet; 1991 Mar; 337(8740):522-3. PubMed ID: 1705643
[No Abstract] [Full Text] [Related]
65. [A clinical study of renal cell carcinoma].
Morozumi M; Ogawa Y; Tanaka T; Yamaguchi K; Sakamoto Y; Kitagawa R
Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1417-22. PubMed ID: 3820818
[No Abstract] [Full Text] [Related]
66. A literature analysis of prognostic factors for response and quality of response of patients with renal cell carcinoma to interleukin-2-based therapy.
Elias L; Hunt WC
Oncology; 2001; 61(2):91-101. PubMed ID: 11528247
[TBL] [Abstract][Full Text] [Related]
67. Systemic therapy in metastatic renal cell carcinoma.
Pyrhönen SO
Scand J Surg; 2004; 93(2):156-61. PubMed ID: 15285569
[TBL] [Abstract][Full Text] [Related]
68. The potential role for neoadjuvant therapy in renal cell carcinoma.
Ho D; Kim HL
Clin Adv Hematol Oncol; 2013 Dec; 11(12):777-82. PubMed ID: 24893281
[TBL] [Abstract][Full Text] [Related]
69. [Therapy and prognosis of hypernephroid kidney carcinoma].
Brühl P; Scheef W; Albert H; Bücheler E
Med Klin; 1975 May; 70(20):873-8. PubMed ID: 805904
[No Abstract] [Full Text] [Related]
70. State-of-the-art management of renal cell carcinoma.
Mourad WF; Dutcher J; Ennis RD
Am J Clin Oncol; 2014 Oct; 37(5):498-505. PubMed ID: 22868246
[TBL] [Abstract][Full Text] [Related]
71. Interferon therapy for renal cell carcinoma.
Muss HB
Semin Oncol; 1987 Jun; 14(2 Suppl 2):36-42. PubMed ID: 3589703
[TBL] [Abstract][Full Text] [Related]
72. Advanced renal cell carcinoma.
Redman BG; Chang AE
Curr Treat Options Oncol; 2000 Dec; 1(5):417-22. PubMed ID: 12057149
[TBL] [Abstract][Full Text] [Related]
73. Renal cell carcinoma.
Reese JH
Curr Opin Oncol; 1991 Jun; 3(3):537-44. PubMed ID: 1716465
[TBL] [Abstract][Full Text] [Related]
74. A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?
Cooney MM; Remick SC; Vogelzang NJ
Curr Urol Rep; 2004 Feb; 5(1):19-24. PubMed ID: 14733832
[TBL] [Abstract][Full Text] [Related]
75. Nephrectomy for metastatic renal-cell cancer.
Schwartz JD
N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936125
[No Abstract] [Full Text] [Related]
76. The use of interferon in renal cell carcinoma.
Muss HB
Eur J Cancer; 1991; 27 Suppl 4():S84-7. PubMed ID: 1724728
[TBL] [Abstract][Full Text] [Related]
77. Renal cell carcinoma.
Long GD
Curr Opin Oncol; 1997 May; 9(3):301-6. PubMed ID: 9229154
[TBL] [Abstract][Full Text] [Related]
78. A patient with advanced renal cell carcinoma managed by multimodal treatment including extensive surgery, interventional radiology and immunotherapy.
Tazaki H; Tachibana M; Marumo K; Hiramatsu K; Handa S; Suzuki H; Maeda K; Ogata K; Sakaguchi H
Keio J Med; 1988 Jun; 37(2):183-97. PubMed ID: 3172621
[No Abstract] [Full Text] [Related]
79. Renal cell carcinoma.
Reese JH
Curr Opin Oncol; 1992 Jun; 4(3):427-34. PubMed ID: 1379830
[TBL] [Abstract][Full Text] [Related]
80. [Current status of treatment of renal cell carcinoma and future problems].
Satomi Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jan; 81(1):1-13. PubMed ID: 1689406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
